iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 Weight Loss Drug Market Size, Share Semaglutide & Tirzepatide: Leading GLP-1
Description
STEP 1 body composition analysis
Most importantly, doses below 2.5 mg weekly have not been studied for efficacy in weight management, meaning there is no evidence that microdosing produces clinically meaningful weight loss
Endocrinology 145, 41764184
July 14, 2026
How do I know if my vial is 10mg/ml or 20mg/ml
